The source of methadone in overdose deaths in Western Virginia in 2004

Journal of Addiction Medicine

Volumn 5, Issue 3, 2011, Pages 188-202

  Weimer, Melissa B ^a   Korthuis, P Todd ^a   Behonick, George S ^b   Wunsch, Martha J ^c  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^b AIT Laboratories   (United States)

^c TASL Clinic   (United States)

Author keywords

Chronic pain; Illicit drug use; Methadone overdose; Prescription monitoring

Indexed keywords

ACETYLSALICYLIC ACID; ALCOHOL; ALPRAZOLAM; BENZODIAZEPINE; CARVEDILOL; CHLORPHENIRAMINE; CITALOPRAM; CLOPIDOGREL; COCAINE; CODEINE; DIAMORPHINE; DIAZEPAM; DIPHENHYDRAMINE; HYDROCODONE; METHADONE; MIRTAZAPINE; MORPHINE; MORPHINE 6 ACETATE; MORPHINE SULFATE; NORDAZEPAM; NORPETHIDINE; OPIATE; OXYCODONE; PANTOPRAZOLE; PARACETAMOL; PHENYTOIN; SALBUTAMOL; SERTRALINE; SIMVASTATIN; UNINDEXED DRUG;

ADULT; AGE; ANALGESIA; AUTOPSY; CAUSAL ATTRIBUTION; CAUSE OF DEATH; CHRONIC PAIN; COMORBIDITY; DRUG INTOXICATION; DRUG MISUSE; DRUG OVERDOSE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; METHADONE RELATED OVERDOSE DEATH; METHADONE TREATMENT; PRESCRIPTION; PRESCRIPTION REFILL; REVIEW; RURAL AREA; SCREENING; SUBSTANCE ABUSE; SUICIDE; SUICIDE ATTEMPT; TOXICOLOGY; UNITED STATES;

ADULT; CAUSE OF DEATH; CORONERS AND MEDICAL EXAMINERS; DRUG PRESCRIPTIONS; FEMALE; HUMANS; MALE; METHADONE; NARCOTICS; OPIATE SUBSTITUTION TREATMENT; OPIOID-RELATED DISORDERS; OVERDOSE; RETROSPECTIVE STUDIES; RURAL POPULATION; STREET DRUGS; SUICIDE; VIRGINIA;

EID: 80052714128     PISSN: 19320620     EISSN: 19353227     Source Type: Journal    
DOI: 10.1097/ADM.0b013e318211c56a     Document Type: Review

References (44)

1. Baker DD, Jenkins AJ. A comparison of methadone, oxycodone, and hydrocodone related deaths in Northeast Ohio. J Anal Toxicol 2008;32: 165-170.
2. Ballesteros M, BudnitzD, SanfordC, Gilchrist J, Agyekum G, Butts J. Increase in deaths due to methadone in North Carolina. JAMA 2003;290:40. (Pubitemid 37432863)
3. Barrett D, Luk A, Parrish RG, Jones TS. An investigation ofmedical examiner cases in which methadone was detected, Harris County, Texas, 1987-1992. J Forensic Sci 1996;41(3):442-448. (Pubitemid 26154293)
4. Cairns A, Roberts I, Benbow E. Characteristics of fatal overdose in Manchester, 1985-1994. Br Med J 1996;313:264-165.
5. Caplehorn JR, Dalton SY, Haldar F, Petrenas AM, Nisbet JG. Methadone maintenance and addicts' risk of fatal heroin overdose. Subst Use Misuse 1996;31:177-196. (Pubitemid 26094982)
6. Darke S, Hall W. Heroin overdose: research and evidence-based intervention. J Urban Health 2003;80(2):189-200. (Pubitemid 37486655)
7. Dickerson ED. Methadone: the question or the answer for US opioid therapy and pharmaco-economics? Support Care Cancer 2001;9:646-647.
8. Eap CB, Buclin T, Baumann P. Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence. Clin Pharmacokinet 2002;41:1153-1193. (Pubitemid 35398691)
9. Federal Register. Standards for Defining Metropolitan and Micropolitan Statistical Areas, US Office of Management and Budget. [Federal Register web site]. December 27, 2000. Available at: http://www.census.gov/population/www/ metroareas/metrodef.html. Accessed November 8, 2009.
10. Fingerhut LA. Increases in poisoning and methadone-related deaths: United States, 1999-2005 [CDC web site]. 2008. Available at: http:// www.cdc.gov/nchs/data/hestats/poisoning/poisoning.pdf. Accessed October 29, 2009.
11. Gagajewski A, Apple FS. Methadone-related deaths in Hennepin County, Minnesota: 1992-2002. J Forensic Sci 2003;48(3):668-671. (Pubitemid 36538842)
12. Gronbladh L, Ohlund L, Gunne L. Mortality in heroin addiction: impact of methadone treatment. Acta Psychiatr Scand 1990;82:223-227. (Pubitemid 20329007)
13. Hall AJ, Logan JE, Toblin RL, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA 2008;300(22):613-620.
14. Inturrisi C, Colburn W, Kaiko R, Houde R, Foley K. Pharmacokinetics and pharmacodynamics of methadone in patients with chronic pain. Clin Pharmacol Ther 1987;41(4):392-400.
15. Intrussi CE, and Verebely K. Disposition of methadone in man after a single oral dose. Clin Pharmacol Ther 1972;13:923-930.
16. Joseph H, Stancliff S, Langrod J. Methadone maintenance treatment (MMT): a reviewof historical and clinical issues. Mt Sinai JMed 2000;67(5, 6):347-364.
17. Katz N, Houle B, Fernandez K, et al. Update on prescription monitoring in clinical practice: a survey study of prescription monitoring program administrators. Pain Med 2008;9(5):587-594.
18. Katz N, Panas L, Kim M, et al. Usefulness of prescription monitoring programs for surveillance-analysis of Schedule II opioid prescription data in Massachusetts, 1996-2006. Pharmacoepidemiol Drug Saf 2010;19(2): 115-123.
19. Leavitt S. Methadone-drug interactions. Addiction Treatment Forum. 3rd ed. Mundelein, IL: Clinco Communications; 2005.
20. Leavitt S, Krantz M. Cardiac considerations during MMT. Addiction Treatment Forum. Mundelein, IL: Clinco Communications; 2003.
21. Lehder D, Arria A, Artigani E, Wish E. Alcohol and drug-related overdose deaths in Maryland: 1997-2001 [Center for Substance Abuse Researchweb site]. 2002. Available at: http://www.cesar.umd.edu/cesar/pubs/20021101.pdf. Accessed November 8, 2009.
22. McLellan AT, Turner B. Prescription opioids, overdose deaths, and physician responsibility. JAMA 2008;300(22);2672-2673.
23. Mikolaenko I, Robinson A, Davis G. A review of methadone deaths in Jefferson County, Alabama. Am J Forensic Med Pathol 2002;23(3): 299-304. (Pubitemid 34988441)
24. Moolhan E, Umbricht A, Epstein D. Therapeutic drug monitoring in methadone maintenance. J Addict Dis 2001;20(2):55-73. (Pubitemid 32982951)
25. National Institutes on Drug Abuse. National Institutes of Health. NIH consensus panel recommends expanding access to and improving methadone treatment programs for heroin addiction. Eur Addict Res 1999;5:50-51.
26. Oregon Department of Human Services. Methadone deaths (and distribution) on the rise. [Oregon web site]. July 15, 2003. Available at: http://www.oregon.gov/DHS/ph/cdsummary/2003/ohd5214.pdf.Accessed November 8, 2009.
27. Oregon Department of Human Services. Opioid-related poisoning deaths in Oregon. [Oregon web site]. September 29, 2009. Available at: http://www.oregon.gov/DHS/ph/cdsummary/cdsum.shtml. Accessed October 29, 2009.
28. Paulozzi L, Logan J, Hall A, McKinstry E, Kaplan J, Crosby A. A comparison of drug overdose deaths involving methadone and other opioid analgesics in West Virginia. Addiction 2009;104:1541-1548.
29. Roxane Laboratories. Dolophine R Hydrochloride tablets (Methadone Hydrochloride Tablets USP) [package insert]. Columbus, OH: Roxane Laboratories Inc; 2000.
30. Roxane Laboratories. Dolophine R Hydrochloride tablets (Methadone Hydrochloride Tablets USP) [package insert]. Columbus, OH: Roxane Laboratories; November 17, 2006.
31. Shah N, Lathrop S, Landen M. Unintentional methadone-related overdose death in NewMexico (USA) and implications for surveillance, 1998-2002. Addiction 2005;100:176-188. (Pubitemid 40255375)
32. Shields LBE, Hunsaker JC, Corey TS, Ward MK, Stewart D. Methadone toxicity fatalities: a review of medical examiner cases in a large metropolitan area. J Forensic Sci 2007;52(6):1389-1395. (Pubitemid 350243438)
33. Sinha S, Callan E, Akpunonu P, Baehren D, Marco C. How does use of a statewide prescription monitoring program affect emergency department prescribing behaviors? [abstract]. Ann Emerg Med 2009;54(3):S14-S15.
34. Sorg M, Greenwald M. Maine drug-related mortality patterns: 1997-2002 [Maine web site]. 2002. Available at: http://www.maine.gov/dhhs/osa/pubs/osa/ 2003/drugreport.pdf. Accessed November 8, 2009.
35. Stitzer M, Griffiths R, McLellan T, Grabowski J, Hawthorne J. Diazepam use among methadone maintenance patients: patterns and dosages. Drug Alcohol Depend 1981;8:189-199. (Pubitemid 12206287)
36. Substance Abuse and Mental Health Services Administration, Center for Substance Abuse Treatment. Methadone Associated Mortality Report of a National Assessment [SAMHSA web site]. 2004. Available at: http://departmentsamhsa.gov/ reports/CSAT1REV.pdf. Accessed May 2007.
37. Substance Abuse and Mental Health Services Administration, National Survey on Drug Use and Health [SAMHSA web site]. 2008. http://www.oas.samhsa. gov/nsduh/2k8nsduh/2k8Results.cfm. Accessed November 8, 2009.
38. Substance Abuse and Mental Health Services Administration, Division of Pharmacologic Therapies. Follow directions how to use methadone safely [SAMHSA web site]. April 2009. Available at: http://www.dpt.samhsa.gov/methadonesafety/ index.aspx. Accessed November 8, 2009.
39. US Department of Justice, Drug Enforcement Administration. Automation of reports and consolidation order's system (ARCOS): Retail Drug Summary Reports, 1998-2002 [USDOJ web site]. 2004. Available at: http://www.deadiversion.usdoj. gov/arcos/retaildrugsummary. Accessed November 8, 2009.
40. US Government Accountability Office. Report to Congressional Requesters. Methadone-Associated Overdose Deaths [SAMHSA web site]. March 2009. Available at: http://www.dpt.samhsa.gov/medications/methadone.aspx. Accessed October 30, 2009.
41. Wheeler. Clinical use of methadone. Am J Hosp Palliat Care 2000:17(3):196-203.
42. Wolf BC, LavezziWA. Sullivan L, Flannagan L. Methadone-related deaths in Palm Beach County. J Forensic Sci 2004;49(2):375-378. (Pubitemid 38298469)
43. Wolff K. Characterization of methadone overdose: clinical considerations and the scientific evidence. Ther Drug Monit 2002;24:457-470. (Pubitemid 34857897)
44. Wunsch MA, Nakamoto K, Behonick G, Massello W. Opioid deaths in rural Virginia: a description of a high prevalence of accidental fatalities involving prescribed medications. Am J Addict 2009;18(1):5-14